|
![]() |
|||
|
||||
OverviewBuilding upon the foundation of basics discussed in the previous edition, the Second Edition provides a more in-depth look at the latest methods and technologies of advanced drug screening, an essential function of drug discovery. With extensively updated content and 21 new chapters, this text examines: quality and efficiency of drug target validation and potential drug compound selection reducing assay costs and improvement in assay technology data quality improvement trends in drug discovery how drug screening can minimize adverse drug effects recent advancements, including: high content screening; protein-protein interactions; high-throughput crystallization; lead optimization; chemoinformatics and microfluidics technologies; target validation by genomics, proteomics, and siRNA; structure-based drug design; automation; and medicinal chemistry Full Product DetailsAuthor: Ramakrishna Seethala (Bristol-Meyers Squibb Company, Princeton, New Jersey, USA) , Litao Zhang (Bristol-Meyers Squibb, Princeton, New Jersey, USA)Publisher: Taylor & Francis Inc Imprint: CRC Press Inc Edition: 2nd edition Volume: 196 Dimensions: Width: 15.20cm , Height: 3.30cm , Length: 22.90cm Weight: 0.793kg ISBN: 9781420061680ISBN 10: 1420061682 Pages: 504 Publication Date: 24 June 2009 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: In Print ![]() This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsReviewsAuthor InformationRamakrishna Seethala, Litao Zhang Tab Content 6Author Website:Countries AvailableAll regions |